Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/20/2012WO2012094512A3 Myocardial tissue targeting peptides
09/20/2012WO2012076985A8 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
09/20/2012WO2012068341A3 Wnt1 for treatment of cardiovascular disorders and injuries
09/20/2012WO2012050611A3 Aptamers to glycoprotein vi
09/20/2012US20120240247 Jnk3 modulators and methods of use
09/20/2012US20120240246 Variant Calpastatins and Variant Calpains for Modulating the Activity or Stability of Calpain
09/20/2012US20120238998 Octanoate-reduced Human Albumin
09/20/2012US20120238749 Inhibitors of interleukin-1 beta converting enzyme
09/20/2012US20120238620 TRYPTOPHANYL-tRNA SYNTHETASE-DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
09/20/2012US20120238592 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocylcial Guanidine
09/20/2012US20120238509 Urocortin 2 analogs and uses thereof
09/20/2012US20120238508 Methods for Promoting Wound Healing and/or Reducing Scar Formation
09/20/2012US20120238507 Alpha helical mimics, their uses and methods for their production
09/20/2012US20120238506 Acacia macrostachya seed extract and compositions containing same
09/20/2012US20120238505 Medicaments
09/20/2012US20120238504 Stable Formulations of Botulinum Toxin in Hydrogels
09/20/2012US20120238503 Human laminin alpha2 chain lg3 domain and active peptides promoting cell adhesion, spreading, migration, and neurite outgrowth
09/20/2012US20120238502 Anti-fibrotic hydrogel compositions
09/20/2012US20120238501 Modulation Of Osteoclast Differentiation
09/20/2012US20120238500 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
09/20/2012US20120238499 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
09/20/2012US20120238498 Agent for the treatment of alopecia
09/20/2012US20120238497 Glp-1 fusion peptides, their production and use
09/20/2012US20120238496 Fusion protein regulating plasma glucose and lipid, its preparation method and use
09/20/2012US20120238495 Novel Cellular Factor-Containing Solution Compositions
09/20/2012US20120238494 Methods for reducing gnrh-positive tumor cell proliferation
09/20/2012US20120238493 Glucagon analogs exhibiting gip receptor activity
09/20/2012US20120238492 Fish protein hydrolysate for the use thereof in inhibiting weight gain and/or weight loss
09/20/2012US20120238491 Immunologically active lipopeptides and methods for use thereof
09/20/2012US20120238490 Methods and compositions for the treatment of metabolic disorders
09/20/2012US20120238489 Method for improving functional properties by means of pulsed light, samples with improved functional properties and uses thereof
09/20/2012US20120238488 Compounds and methods for treating neoplasia
09/20/2012US20120238487 Polymer composition useful as a pharmaceutical carrier
09/20/2012US20120237972 Mammalian-type glycosylation in plants
09/20/2012US20120237624 Vigna unguiculata seed extract and compositions containing same
09/20/2012US20120237614 Peptide able to disrupt the protein complex between the his273 mutaded p53 protein and the oncosuppressive p73 protein in tumor cells and therapeutic uses thereof
09/20/2012US20120237593 Formulations of Guanylate Cyclase C Agonists and Methods of Use
09/20/2012US20120237590 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012US20120237589 Amphoteric liposomes comprising imino lipids
09/20/2012US20120237588 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20
09/20/2012US20120237587 Combination preparation including a corticosteroid and exosomes
09/20/2012US20120237557 Bioactive carbon-nanotube agarose composites for neural engineering
09/20/2012US20120237552 Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments
09/20/2012US20120237550 Maintaining Antibody-Binding Activity Of Immunosuppressant Drug Conjugates
09/20/2012US20120237548 Pharmaceutical compositions containing botulinum neurotoxin
09/20/2012US20120237533 Compositions and Methods for Inducing Apoptosis in Prostate Cancer Cells
09/20/2012US20120237527 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
09/20/2012US20120237525 Combination preparation including a cytokine antagonist and corticosteroid
09/20/2012US20120237514 Vascular endothelial cell growth factor antagonists and uses thereof
09/20/2012US20120237504 Compositions and methods for treating inflammation and fibrosis
09/20/2012US20120237501 Anti-HIV Peptides and Methods of Use Thereof
09/20/2012US20120237499 Modulators of TDP-43 Mediated Toxicity and Methods of Use Thereof for Identifying Agents Having Efficacy for the Treatment and Prevention of Proteinopathies
09/20/2012US20120237497 Compositions and methods for producing clostridial collagenases
09/20/2012US20120237496 Protease variants
09/20/2012US20120237495 Method of treatment using solubilized protein composition obtained from eggshell membrane
09/20/2012US20120237493 Nucleic acids encoding a mut-t domain-containing polypeptide
09/20/2012US20120237492 Treatment of submental fat
09/20/2012US20120237491 Phage derived antimicrobial activities
09/20/2012US20120237480 2'allene-substituted nucleoside derivatives
09/20/2012US20120237479 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
09/20/2012US20120237478 Modulators of pharmacokinetic properties of therapeutics
09/20/2012US20120237477 Methods and compositions for treating post-myocardial infarction damage
09/20/2012US20120237476 Pharmaceutical Compositions for Sustained Release Delivery of Peptides
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120237474 Fluorinated diaryl urea derivatives
09/20/2012US20120237473 Compositions And Methods For Cell Based Retinal Therapies
09/20/2012US20120237472 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
09/20/2012US20120237464 Hydrophilically-modified silicone compositions
09/20/2012US20120237447 Star polymer nanoshells and methods of preparation thereof
09/20/2012US20120237443 Functionalizing implantable devices with a poly (diol citrate) polymer
09/20/2012US20120234718 Pharmaceutical formulation for use in spinal fusion
09/20/2012CA2846786A1 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
09/20/2012CA2835475A1 Yeast-brachyury immunotherapeutic compositions
09/20/2012CA2830407A1 Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
09/20/2012CA2830240A1 Methods of treating breast cancer with anthracycline therapy
09/20/2012CA2829586A1 Methods and compositions relating to mesenchymal stem cell exosomes
09/20/2012CA2828657A1 Use of low dose il-2 for treating autoimmune - related or inflammatory disorders
09/20/2012CA2828616A1 Uses of modified elr-cxc chemokine g31p to treat cancer
09/20/2012CA2828504A1 Antagonists of the interleukin-1 receptor
09/20/2012CA2827275A1 Copolymer-1, process for preparation and analytical methods thereof
09/19/2012EP2500438A2 Novel compositions and methods for the treatment of psoriasis
09/19/2012EP2500432A2 Analogues of human pancreatic polypeptide (hPP) and their effects on feeding behaviours
09/19/2012EP2500419A1 A respiratory syncytial virus with a genomic deficiency complemented in trans
09/19/2012EP2500360A2 Compositions and Methods for Diagnosing and Treating Cancer
09/19/2012EP2500350A2 Composite of a protein comprising zinc oxide-bonding peptides and zinc oxide nanoparticles, and use thereof
09/19/2012EP2500042A1 Cell sheet for myocardial regeneration, manufacturing method, and method of usage therefor
09/19/2012EP2500032A1 APO-2 ligand/trail variants and uses thereof
09/19/2012EP2500031A2 Compositions and Methods for Treating Vascular Permeability
09/19/2012EP2500030A2 Use of complement pathway inhibitors to treat ocular diseases
09/19/2012EP2500029A1 Therapeutic agent for gastrointestinal diseases
09/19/2012EP2500021A1 Therapeutic uses of VX-950
09/19/2012EP2500014A2 Slow release pharmaceutical composition made of microparticles
09/19/2012EP2499497A1 Human fertility test using dpy19l2
09/19/2012EP2499245A2 Glycosyl transferase from chinese hamster and related methods
09/19/2012EP2499165A2 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
09/19/2012EP2499152A1 Tubulin inhibitors
09/19/2012EP2498810A1 Treatment of sleep disordered breathing with neurotoxin
09/19/2012EP2498806A1 Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
09/19/2012EP2498805A1 Aqueous composition comprising gold nanoparticles, serum albumin and/or collagen for laser tissue welding
09/19/2012EP2498804A2 Factor viii b cell epitope variants having reduced immunogenicity
1 ... 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 ... 3163